Commercial partnerships for Switzerland

Curatis is your partner company of choice for your products in Switzerland.

Customised and efficient partnership
Curatis is keen to offer its partners a customised package for the commercialisation of pharmaceutical products in Switzerland, taking into account the specific needs and requirements of the partner company and its product(s).

Curatis Core competencies

  • specialty care drugs, orphan drugs as well as antidotes
  • market access (registration, pricing and reimbursement)
  • marketing and sales activities for specialised products
  • early access programmes
  • state-of-the-art quality and pharmacovigilance know-how
  • efficient and fast operational processes and communication with partners
  • accommodation and implementation of partner-specific requirements

Commercial partnerships for Core European countries Germany, France, Italy and UK

Commercial partnerships for Core European countries Germany,In line with the company’s geographic expansion strategy, Curatis is also looking for distribution partnerships for ultra orphan, orphan and specialty care medicines for Germany, France, Italy and UK.France, Italy and UK

Partnerships for developing novel medicines

To ensure efficient and state-of-the art developments of its pipeline projects, Curatis maintains co-development partnerships with other innovative small and medium-sized biotech/pharmaceutical companies, and also with best-practice contract research and manufacturing organisations. Curatis is looking for co-investors and/or larger pharmaceutical companies for licensing or co-development arrangements for the late stage clinical development of its pipeline projects.
For more information, please contact us at info(at)